We are developing an international biotech hub aimed to bring Greece to the forefront of health and life sciences.
Our vision is to become a globally competitive biotechnology hub based in Greece.
Our mission is to enhance innovation in the biopharmaceutical industry and create value, through enabling collaborations between Academia, start-up entrepreneurship, venture capitals and industry, with the aim of expediting the drug discovery and development process for the benefit of patients worldwide.
Our goal is to advance drug discovery & development in Greece by providing a range of supporting services and the guidance of experienced pharma/biotech executives and entrepreneurs.
Athens LifeTech Park is an ELPEN initiative, which has been designed in collaboration with Greek scientists within Greece, coupled with the valuable guidance of the Greek scientific Diaspora.
It is incorporated as a stand alone, not-for-profit, entity (AMKE) and its operation is overseen by an independent Board of Directors.
The distinguished Greek scientist Dr. Dimitrios Iliopoulos visited the under-construction “Athens LifeTech Park”, in the context of collaboration that has been developed.
The Vice President of the European Commission for promoting our European Way of Life, Margaritis Schinas, and the Director General of Medicines for Europe, Adrian Van Den Hoven, visited the under construction Athens LifeTech Park in Spata.
The Deputy Minister for Development and Investments, Mr. Christos Dimas visited the under-construction first biotechnology Park in Greece.
We believe Greece has the potential to play a bigger role in the global life sciences ecosystem, by leveraging its high quality scientific capital.
If you want to contribute to our Vision, get in touch with us!
Ελληνικά
English